DoW Parkinsons, Investigator-Initiated Research Award

The Parkinson’s Investigator-Initiated Research Award is offered by the Defense Health Agency through the Congressionally Directed Medical Research Programs as part of its broader Parkinson’s Research Program. This federal funding opportunity is designed to support highly rigorous, multidisciplinary, and high-impact research projects that contribute meaningfully to the understanding and treatment of Parkinson’s disease. The program operates under congressional appropriations and is aligned with a mission to improve the health and quality of life of service members, veterans, their families, and the general public. It emphasizes translational research that can move from basic discovery to clinical application. The primary purpose of this award is to fund innovative research that addresses at least one of the program’s designated focus areas, which include disease heterogeneity, development of model systems, identification of biological mechanisms or biomarkers, and interventions targeting unmet medical needs. Projects may span the full research spectrum, including basic science, translational studies, and clinical trials. Applicants are expected to present strong scientific rationale supported by preliminary data and demonstrate feasibility through well-developed methodologies. The program encourages multidisciplinary collaboration and provides an option for multiple principal investigators to jointly lead projects. Funding is structured with a total program allocation of approximately ten million dollars, supporting around five awards. Each award may request up to two million dollars in total costs over a maximum performance period of three years. Funds may be used for a wide range of research-related expenses, including personnel, materials, and limited travel for collaboration and dissemination of findings. However, restrictions apply to ensure appropriate use of funds, including limits on travel and requirements that all costs align with institutional negotiated rates. Cost sharing is not required, which lowers the financial barrier to participation for eligible organizations. Eligibility is broad and inclusive, allowing applications from both domestic and international organizations across sectors, including academic institutions, government entities, nonprofits, and for-profit organizations. Principal investigators must be independent researchers affiliated with eligible institutions and are required to dedicate at least fifteen percent of their professional effort to the project. The program encourages participation from investigators across diverse disciplines and supports collaborative efforts that leverage expertise from academia, industry, and government agencies. The application process follows a two-step submission model. Applicants must first submit a pre-application in the form of a letter of intent through the eBRAP system. Following this, a full application is submitted either through Grants.gov or eBRAP depending on the organization type. The full application requires extensive documentation, including a project narrative, technical and lay abstracts, statement of work, impact statement, and supporting materials such as data sharing plans and letters of support. Additional attachments are required for projects involving clinical trials, animal studies, or human subjects research. Applications are evaluated through a two-tier review process consisting of peer review and programmatic review. Peer review assesses scientific merit, feasibility, impact, and qualifications of the research team, while programmatic review considers alignment with program priorities and overall portfolio balance. The evaluation criteria emphasize rigorous study design, potential for meaningful impact, and relevance to military and public health needs. Successful applicants are notified following programmatic review, and awards are issued through formal agreements with the Department of Defense. The timeline for this opportunity includes a pre-application deadline in October and a full application deadline in early November, with review processes occurring in the following months and awards expected by late the following fiscal year. The program operates on an annual cycle, making it a recurring opportunity for researchers. Applicants are advised to maintain active registrations in required federal systems and to begin preparation well in advance due to the complexity of submission requirements and review standards.

Ensure strong preliminary data and feasibility; clearly align with PRP focus areas; emphasize clinical impact and military relevance; demonstrate multidisciplinary expertise